Sanctuary Advisors LLC Purchases Shares of 7,886 Utah Medical Products, Inc. $UTMD

Sanctuary Advisors LLC purchased a new position in Utah Medical Products, Inc. (NASDAQ:UTMD) during the 2nd quarter, HoldingsChannel reports. The firm purchased 7,886 shares of the medical instruments supplier’s stock, valued at approximately $544,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Utah Medical Products during the second quarter valued at $14,051,000. Rice Hall James & Associates LLC purchased a new position in Utah Medical Products during the second quarter valued at approximately $4,923,000. Bank of New York Mellon Corp purchased a new position in shares of Utah Medical Products during the 2nd quarter valued at $2,363,000. Bard Associates Inc. purchased a new position in Utah Medical Products in the second quarter valued at about $1,279,000. Finally, Brandes Investment Partners LP increased its holdings in Utah Medical Products by 4.0% in the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock worth $19,660,000 after buying an additional 13,392 shares during the last quarter. Institutional investors and hedge funds own 69.60% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Utah Medical Products from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday. One analyst has rated the stock with a Hold rating, According to MarketBeat, Utah Medical Products has an average rating of “Hold”.

Utah Medical Products Price Performance

NASDAQ:UTMD opened at $72.77 on Friday. The company has a fifty day moving average price of $70.27 and a 200 day moving average price of $67.22. The stock has a market cap of $231.41 million, a P/E ratio of 22.19 and a beta of 0.35. Utah Medical Products, Inc. has a one year low of $53.66 and a one year high of $75.75.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 8.74% and a net margin of 29.04%.The firm had revenue of $8.53 million for the quarter.

Utah Medical Products Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, October 5th. Investors of record on Thursday, September 17th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Thursday, September 17th. Utah Medical Products’s dividend payout ratio (DPR) is 37.80%.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).